Cleared Traditional

K230937 - Alinity i Total ß-hCG Reagent Kit, GLP systems Track (FDA 510(k) Clearance)

Jun 2023
Decision
63d
Days
Class 2
Risk

K230937 is an FDA 510(k) clearance for the Alinity i Total ß-hCG Reagent Kit, GLP systems Track. This device is classified as a System, Test, Human Chorionic Gonadotropin (Class II - Special Controls, product code DHA).

Submitted by Abbott Laboratories (Iriving, US). The FDA issued a Cleared decision on June 5, 2023, 63 days after receiving the submission on April 3, 2023.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1155.

Submission Details

510(k) Number K230937 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 03, 2023
Decision Date June 05, 2023
Days to Decision 63 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code DHA — System, Test, Human Chorionic Gonadotropin
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1155

Similar Devices — DHA System, Test, Human Chorionic Gonadotropin

VITROS Immunodiagnostic Products Total ß-hCG II Reagent Pack
K233581 · Ortho-Clinical Diagnostics · May 2024
Alinity i Total B-hCG Reagent Kit, Alinity c Glucose Reagent Kit, Alinity c ICT Sample Diluent, Alinity ci-series
K230790 · Abbott Laboratories · May 2023
Access Total ßhCG (5th IS)
K221990 · Beckman Coulter, Inc. · Dec 2022
Elecsys HCG STAT
K203227 · Roche Diagnostics · Aug 2021
ADVIA Centaur® Total hCG assay
K200210 · Siemens Healthcare Diagnostics, Inc. · Jul 2021